MARKET

INMB

INMB

Inmune Bio Inc
NASDAQ
7.95
-0.09
-1.12%
After Hours: 8.90 +0.95 +11.95% 19:21 03/14 EDT
OPEN
8.15
PREV CLOSE
8.04
HIGH
8.42
LOW
7.77
VOLUME
224.71K
TURNOVER
--
52 WEEK HIGH
12.72
52 WEEK LOW
4.320
MARKET CAP
211.40M
P/E (TTM)
-3.6434
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at INMB last week (0303-0307)?
Weekly Report · 5d ago
Inmune Bio (INMB) Receives a Buy from Scotiabank
TipRanks · 03/05 13:17
INmune Bio Reports Promising Phase I/II Trial Results
TipRanks · 03/04 19:48
Weekly Report: what happened at INMB last week (0224-0228)?
Weekly Report · 03/03 12:31
Weekly Report: what happened at INMB last week (0217-0221)?
Weekly Report · 02/24 12:32
Weekly Report: what happened at INMB last week (0210-0214)?
Weekly Report · 02/17 12:28
INmune Bio Is Maintained at Buy by Maxim Group
Dow Jones · 02/13 23:18
INmune Bio Price Target Raised to $30.00/Share From $22.00 by Maxim Group
Dow Jones · 02/13 23:18
More
About INMB
INmune Bio Inc. is a clinical-stage biotechnology company focused on developing treatments that target the innate immune system to fight disease. It has two therapeutic platforms: a Dominant-Negative Tumor Necrosis Factor Platform (DN-TNF, XPro, XPro1595 or pegipanermin) and a Natural Killer (NK or INKmune) platform. The DN-TNF product platform utilizes dominant-negative technology to selectively neutralize soluble TNF, a key driver of innate immune dysfunction and a mechanistic driver of many diseases. DN-TNF product candidates are in clinical trials to determine if they can treat cancer (INB03) Mild Alzheimer's disease, Mild Cognitive Impairment and treatment-resistant depression (XPro). The NK Cell Priming Platform includes INKmune developed to prime a patient's NK cells to eliminate minimal residual disease in patients with cancer. Its product platforms utilize a precision medicine approach for the treatment of hematologic and solid tumor malignancies, and chronic inflammation.

Webull offers INmune Bio Inc stock information, including NASDAQ: INMB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, INMB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading INMB stock methods without spending real money on the virtual paper trading platform.